Recent News

• 04.10.2025 - Eyenovia Provides Development Update on Optejet User Filled Device (UFD)
• 04.10.2025 - Eyenovia Provides Development Update on Optejet User Filled Device (UFD)
• 03.20.2025 - Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
• 03.20.2025 - Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
• 02.26.2025 - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
• 02.26.2025 - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
• 02.24.2025 - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
• 02.24.2025 - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
• 02.05.2025 - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device
• 02.05.2025 - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Recent Filings

• 03.31.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 03.20.2025 - EX-99.1 EX-99.1
• 03.20.2025 - 8-K Current report
• 03.05.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.25.2025 - 8-K Current report
• 02.24.2025 - 8-K Current report
• 01.31.2025 - 8-K Current report
• 01.28.2025 - EX-99.1 EX-99.1